Noteworthy, it has been reported that an increase in the frequency of CD14+CD169+ cells may be associated with the development and progression of CRC and a concomitant rise of both pro-tumor (M2) and anti-tumor (M1) monocytes and infiltrating macrophages [31]. Here, SIGLEC1 is linked to neoplasm.